Skip to main content
. 2021 Nov 25;23(5):485–493. doi: 10.1111/hiv.13206

TABLE 1.

Demographic and clinical characteristics of the study population

N = 28 089
n (%)
Age group (years)
< 20 34 (0.1%)
20–29 1748 (6.2%)
30–39 6304 (22.4%)
40–49 9820 (35.0%)
50–59 5818 (20.7%)
60–69 2946 (10.5%)
≥ 70 1419 (5.1%)
Sex
Male 25 817 (91.9%)
Female 2272 (8.1%)
AIDS‐defining illness 15 957 (56.8%)
AIDS 10 170 (36.2%)
Pneumocystis jirovecii pneumonia 3963 (14.1%)
HIV disease resulting in cytomegaloviral disease 1790 (6.4%)
HIV disease resulting in mycobacterial infection 1750 (6.2%)
HIV candidiasis 806 (2.9%)
Diabetes 12 034 (42.8%)
Hypertension 6808 (24.2%)
Lipid disorders 11 142 (39.7%)
Vascular diseases 3116 (11.1%)
Angina 1778 (6.3%)
Stroke 1541 (5.5%)
Myocardial infraction 362 (1.3%)
Hypertensive heart disease 95 (0.3%)
Chronic kidney disease 1633 (5.8%)
Haemodialysis 168 (0.6%)
Malignant diseases a 4305 (15.3%)
AIDS‐defining cancers 2432 (8.7%)
Non‐AIDS‐defining cancers 2485 (8.8%)
Psychiatric disorders 8064 (28.7%)
Mania and depression 5526 (19.7%)
Anxiety 4055 (14.4%)
Psychosis 2297 (8.2%)
Dementia 163 (0.6%)
Osteoporosis 3572 (12.7%)
Hepatitis B infection 3935 (14.0%)
Hepatitis C infection 3929 (14.0%)
Other psychoactive substance related disorders 361 (1.3%)
a

Number of people living with HIV (PLWH) with malignant disease is 4305; PLWH may have more than one type of malignancy.